Ureteral Obstruction Market Growth, SWOT Analysis and Growth Prospects | Forecast To 2023

Ureteral Obstruction Market Share, Growth And Trends Analysis By Type (Acute, Chronic) By Diagnosis (Ultrasound, Bladder Catheterization, Others) By Treatment (Surgery, Drugs) By Equipment (Devices, Consumables, Others) By End Users - Global Forecast Till 2023 

Market Highlights

The global Ureteral Obstruction Market is growing at a rate of 8.5 % and is expected show a similar trend during the forecast period. Ureteral obstruction or urinary tract obstruction is a condition of blockage of urine through the urinary tract, which may be complete or partial. In Ureteral obstruction the urine may refluxes backward into your kidneys. Ureteral obstruction is curable, but if not treated, can lead to loss of kidney function, sepsis and eventually death. Other severe consequences are kidney stones, and infection of the urinary tract. Mild symptoms generally in partial blockage are pain in a side, abnormal urine flow and urinating at night, acute stinging pain etc. Ureteral obstruction is caused by injuries such as a pelvic fracture, ureter, kidneys, bladder or colon cancer, kidney stones in ureter etc.

The market for ureteral obstruction is highly fragmented due to large number of players especially in the devices segment which has put pressure on the profit margin, rise of low quality and low-cost products especially catheters which reduces the market of high-quality products. Also, the market for ureteral obstruction is highly dependent on product development strategy such as miniaturization of ureter stents, development of coated ureter stents. The drug segment is growing at a slow pace due to saturation of the market. Considering all these factors, the market for ureteral obstruction is expected to grow at a CAGR of ~ 8.5 % during 2017-2023.

Global Ureteral obstruction market Players:

Key players profiled in the report are C. R. Bard, Inc., Boston Scientific Corporation, Cook Medical Inc., Medline Industries, Inc., Coloplast A/S, DISA Vascular, Terumo Europe NV, Medtronic, Novartis AG, Johnson and Johnson and others.

Segmentation:

The global ureteral obstruction market is segmented based on type, diagnosis, treatment, equipment and end users. Based on type, the market has been segmented as acute and chronic. Based on the diagnosis, the market has been segmented as ultrasound, bladder catheterization, computed tomography (CT), magnetic resonance imaging (MRI), voiding cystourethrography (VCUG), pyelography, endoscopy, blood and urine tests and others.

Based on the treatment, the Ureteral Obstruction Market has been segmented as surgery (ureteral stent, nephrostomy, open laparoscopy, catheterization, robot-assisted laparoscopy, others) and drugs (antibiotics, pain killers, others). Based on the equipment, the market has been segmented as devices (catheters, stents, others) and consumables (diagnostic reagents, urinary sample collectors, others) and others. Based on the end users, the market has been segmented as hospitals and clinics, research, others.

Brows More Healthcare Related Research Reports

Middle East and Africa Clinical Trial Imaging Market-Forecast to 2022 | MRFR

Saudi Arabia Medical Devices Market Report – Forecast 2023 | MRFR

Artificial Retina Market Trends Analysis, Size | Applications, 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

Needle Biopsy Market Key Players, Dynamics, Insights | Forecast To 2023

Needle Biopsy Market Share, Growth And Trends Analysis By Type (Fine-Needle Aspiration Biopsy, Core Needle Biopsy, Vacuum-Assisted Biopsy, Image-Guided Biopsy) By Utility (Disposable, Reusable), By Applications (Tumor, Infection, Inflammation, Others) - Global Forecast Till 2023

Market Highlights

The global needle biopsy market is growing at a rate of 5.2 % and is expected show a similar trend during the forecast period. The needle biopsy market is chiefly driven by product development and the fall in prices of raw materials and components. The increasing cases of cancers and growing usage of biopsy needles is driving the market. Companies should focus on improving the distribution efficiency so as to reduce the pressures on prices due to huge market fragmentation. Distributional agreements between large players and advanced products such as multilayer needles will be extremely beneficial.

The emergence of needle biopsy is estimated to pose the greatest threat to the biopsy needle market. Needle biopsy offers non-invasive diagnostic tests for detecting cancer as it used liquids such as blood, urine, saliva etc. to detect malignancy. Increasing automation will enhance the capabilities of needle biopsy and it may substitute the needle biopsy procedures. Real time progression of cancers is also possible in needle biopsy which raises the level of threat it possesses to needle biopsy. The falling cost of products due to greater market fragmentation and the emergence of Chinese companies is expected to put additional pressures on prices. 

In our estimates vacuum assisted needle biopsy will be the fastest growing segment. The increasing screening rates for cancers through the world will stimulate the market. Among the various cancers, breast cancer is expected to generate the largest use of needle biopsy. Needle Based Biopsy Guns is another lucrative strategy that is being pursued by many players. Core needle biopsy has a higher efficiency and detectability rate than fine needle aspiration biopsy. There is increasing bias to use core needle biopsy in combination with needle aspiration biopsy to achieve highest sensitivity and detectability. Thus, the two tests are complementary, and the effectiveness rate is highest with both tests are done together.

The growing stringent regulation and standards for medical devices, and the increasing uncertainty about reimbursement in the US are threatening the growth of the market.

Global Needle biopsy Market Players:

Key players profiled in the report are Boston Scientific Corporation, Cook Medical, CareFusion Corporation, Hologic, Inc., and Cardinal Health, Inc., Medax, C. R. Bard, Inc., Möller Medical GmbH, Becton, Dickinson and Company, Hakko co. ltd., Kompass, Argon Medical Devices, Inc. and others.

Segmentation:

The global needle biopsy market is segmented based on type and applications. Based on type, the market has been segmented as fine-needle aspiration biopsy, core needle biopsy, vacuum-assisted biopsy and image-guided biopsy. Based on the utility, the market has been segmented as disposable and reusable. Based on the applications, the needle biopsy market has been segmented as tumor, infection, inflammation and others.

Brows More Healthcare Related Research Reports

Neuromodulation Devices Market Trends, Share | Size Analysis, 2023

Cardiopulmonary Resuscitation Market Trends, Size | Share Analysis, 2023

Cervical Dystonia Market Trends Analysis, Share | Size, Forecast To 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team has supreme objectives to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

Lichen Sclerosus Treatment Market Size, Share, Demand and Growth | Forecast To 2023

Lichen Sclerosus Treatment Market Application, Trends and Share Analysis By Type of Treatment (Drug Therapy, Surgery), By Mode Of Administration (Topical, Oral, Iv And Others), By End Users (Hospitals, Dermatology Clinics, Pharmacies, And Others) - Global Forecast Till 2023

Market Highlights

The global lichen sclerosus treatment market is expected to grow at a CAGR of 7.8% during the forecast period and is estimated to reach USD 150 million by 2023. Lichen sclerosus is underdiagnosed condition of the anogenital region. It is often painful and itchy and may cause sexual and urinary dysfunction.

Prevalence of skin diseases is increasing across the globe.  People are unaware of most of the rare skin diseases, which is one of the driving factors of the market. Moreover, lichen sclerosus treatment market is driven by growing prevalence of this disease in both developed and developing countries. Additionally, increasing geriatric population with skin disease, which remain untreated for a long period of time boost the market growth.

Taste the market data and market information presented through more than 115 market data tables and figures spread over 110 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Lichen sclerosus treatment market research report–Global forecast till 2023.”

Major Players in Lichen Sclerosus Treatment Market

Some of the key players in the global market are AstraZeneca plc, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Merck & Co., Inc., Pfizer Inc., Sandoz AG (Novartis AG), Sanofi S.A., Valeant Pharmaceuticals, and Zylera Pharmaceuticals.

Regional Analysis

The global lichen sclerosus treatment market consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East & Africa.

The Americas dominates the global lichen sclerosus treatment market. It comprises of two regions namely North America and South America. North America is the largest market owing to rising prevalence of skin diseases in the American counties and increasing geriatric population with skin diseases. According to the American Academy of Dermatology, 50% of Americans over age 65 have skin disease.

In the Europe, extensive demand for skin care and topical products to treat skin diseases drives the market growth. Moreover, increasing investment in research & development in developing new treatment methods for skin related diseases add fuel to the growth of the market.  

Asia Pacific is the fastest growing and potential market for the lichen sclerosus treatment owing to increasing number of dermatology clinics and rising prevalence of lichen sclerosus in the developing countries. Rising prevalence of vulva’s lichen sclerosus in women act as a risk factor for vulvar cancer also drives the growth of this market.  

The Middle East & Africa is expected witness steady growth due to rising demand for primary healthcare services such as diagnosis and medical devices.

Segmentation

The global lichen sclerosus treatment market is segmented on the basis of type of treatment, which includes drug therapy, and surgery. He drug therapy is further segmented into corticosteroid, immune modulating drugs, retinoid like agents, and others. The surgery is further segmented into laser surgery, circumcision, and others. On the basis of mode of administration, the market is segmented into oral, topical, IV (Intravenous), and others. The oral administration is further segmented into tablets, capsule and others. The topical administration is further segmented into creams, ointment, and others. On the basis of end user, the market is segmented into hospitals, dermatology clinics, pharmacies, and others.

Brows More Healthcare Related Research Reports

Global Suture wire Market Research Report - Forecast to 2023 | MRFR

Neuropsychiatric Disorders and Treatment Market size, Insights | Industry Trends, 2023

Nanobots Market Size, Trends | Insights and Share Analysis, 2023 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact

Market Research Future

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

Image Guided Radiotherapy Market Profile, Outlook and Segmentation | Forecast To 2023

Market Research Future Published a Half-Cooked Research Report on Image Guided Radiotherapy Market Research Report.

Market Research Future (MRFR) in its recently published study report asserts that the global image guided radiotherapy market will register a CAGR of 15.8% during 2017 – 2023, accruing pervasively by 2023. Image Guided Radiotherapy or IGRT is a type of conformal radiotherapy involving the use of different scans and X-rays to treat a specific area of cancer growth. Image-guided radiation therapy integrated with a technique called intensity-modulated radiotherapy (IMRT), enables to shape the radiation beam to the outline of tumors in real time, even as they move in the body. This treatment targets tumors with pinpoint accuracy, and minimize the side-effects caused by damage to healthy tissue.

At the same time, the treatment allows scientists in the Centre for Cancer Imaging (ICR’s) to push boundaries with the very latest in single and combined imaging technologies to visualize tumors precisely and study their behavior, physiology, and growth. All these commutatively add up to deliver effective outcomes in the treatment of various types of cancer such as skin cancer, lung cancer, lung cancer, and others.

Therefore, the image-guided radiotherapy is considered as a proven, effective cancer treatment which is allowing its market to accrue vastly. Certainly, technological advancements transpired in the medical science and biotechnology is a major driving force that escalates the market on the global platform, improving the outlook for cancer treatments and sufficiently controlling the spread of the diseases.

Cancer cases are increasing rapidly, worldwide, and the changing lifestyle is the main culprit.  Improving economic conditions are playing the main role in increasing the purchasing power of people, increasing access to the modern lifestyle. Addictions such as tobacco and alcoholism are again some of the dominant risk factor helping the cancerous cells and tumors to develop.

Additionally, factors such as increasing population, heredity reasons and genetic mutations (abnormal changes), exposures to harmful radiation along with the increasing per capita health care expenditures are substantiating the market growth. Besides, increasing governmental initiatives are supporting the market growth, spreading the awareness among people.

Conversely, the high cost of the treatment & devices, along with the side effects of the therapy and long approval time for the clinical trials are obstructing the market growth, slowing the market growth over the forecasted period. However, unavailability of comprehensive treatments especially in the developing regions is expected to provide the ample scope to the market to evolve further, prompting substantial investments for R&D to bring more novelty and betterments in the image-guided radiotherapy.

Global Image Guided Radiotherapy Market – Segments

By Types:  Soft-Tissue Imaging, Lung MRI, Simplifying Cardiac MRI, Simplifying MRI-Conditional Implant Scans, and Silent MRI Scanning.

By Technologies: Radiation-Based (electronic portal imaging devices (EPID), cone beam CT, Fan beam, and others.), and Non-Radiation Based Systems (ultrasound-based systems, camera-based or optical tracking systems, MRI-guided IGRT, and others.), among others.

By Devices: X-ray computed tomography (digital X-ray, computed tomography (CT), conventional CT, optical tracking, cone beam, MVCT, and others.), magnetic resonance imaging (MRI), positron emission tomography, and others.

By End-users: Hospitals, Smart Cancer Centers, and Research Institutes among others. 

By Regions:  APAC, North America, Europe, and the Rest-of-the-World.

Global Image Guided Radiotherapy Market – Geographical Analysis

The North American region dominates the global image guided radiotherapy market.  The market growth is majorly supported by the radiotherapy market in the US which is growing due to the large patient pool and substantial healthcare expenditures.

Furthermore, the increasing prevalence of types of cancer and thyroid fuelled by the consequences of the wrong lifestyle fosters the market growth in the region. Moreover, factors such as technological advancement and well-spread awareness among people towards the benefits of this therapy support the market growth.

The image guided radiotherapy market in the European region rapidly emerging as another lucrative market owing to the increasing number of cancer patients in the region. Furthermore, the proliferation of advanced treatment facilities alongside the availability of skilled medical professionals, and the government support for research & development drives the market in the region.

The Asia Pacific region accounts for another promising market for the image-guided radiotherapy. Factors substantiating the market growth include the increasing prevalence of cancer, spreading awareness among people about cancer, and the availability of new treatment methods. Proliferating markets in China and India majorly contribute to the market growth in the region.

The Image Guided Radiotherapy market in the Middle East and Africa region is expected to witness a slow growth due to the lack of awareness of the chronic diseases and the limited treatment facilities in these regions.

Global Image Guided Radiotherapy Market – Competitive Landscape

The market is fiercely competitive due to the presence of numerous large & small players, having the international presence. The global market for image guided radiotherapy appears intensely competitive with the several large and small players forming a competitive edge in the market incorporating strategic partnership, collaboration, acquisition, expansion, and technology launch.  Significant investments are transpired in the field to bring innovations in the therapy and clinical trials.

Key Players:

Some of the imminent players in the image guided radiotherapy market are General Electric Company (US), ViewRay (US), Hitachi, Ltd. (Japan), Koninklijke Philips N.V. (Netherland), Siemens AG (Germany), Varian Medical Systems, Inc. (US), Toshiba Corporation (Japan), Vision RT Ltd. (UK), XinRay Systems (US), C-RAD (Sweden), and Scranton Gillette Communications (US).

Industry/ Innovation/Related News:

ViewRay, Inc. (US), a medical technology company announced the unveiling of its new, MRIdian MR-Image guided radiation therapy in the Acibadem Maslak Hospital in Istanbul, Turkey for the Next Generation Cancer Care.

ViewRay's MRIdian® Linac is the world's first system to combine MRI guidance and linear accelerator radiation delivery.  These treatments mark the first in Turkey.

MRIdian MRI-guided radiotherapy represents the latest advancement in the field of radiation oncology that allows clinical improvements in visualization and precision daily plan adaptation, providing the tools to deliver higher and potentially more effective radiation doses.

Brows More Healthcare Related Research Reports

Medical Billing Market Size, Trends | Growth Analysis, 2023

Cholesterol Management Devices Market Size, Growth | Share Analysis, 2023

Artificial Insemination Market Size Analysis, Share | Industry Trends, 2025

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Hybrid Operating Room Market Insights, Growth and Investment Feasibility | Forecast To 2023

Market Research Future Published a Half-Cooked Research Report on  Hybrid Operating Room   Market Research Report

Recognizing the traction the market is vibrating currently with and the potential this market holds to grow further, Market Research Future (MRFR) in its recently published study report asserts that the global Hybrid Operating Room market is expected to evaluate at exponential value by 2023, registering an impressive CAGR of 12.5% over the assessment period (2017 – 2023). 

Hybrid Operating Room (Hybrid OR) is an advanced surgical theatre that is highly equipped with futuristic medical imaging devices such as fixed C-Arms, and CT/ MRI scanners, and others so as to combine developed imaging capability with a fully functioning operating room. In Hybrid OR settings, various hybrid processes can be performed with a portable e-arm as well as optimal imaging and technical functionality.

Augmenting demand for state of the art operating rooms heading with growing demand for technologically advanced surgical process and an upsurge in the caregiving facilities drive the market growth of hybrid operating room.  Technical advancements transpired in the healthcare domain across the globe, is acting as a key driving force to escalate the market growth to furthered heights.

A hybrid operating room has become an integral part of hospitals and clinical setting, providing good outcomes by improving the surgical processes. This prominence is garnering huge popularity for Hybrid OR, leading to increase its adoption. Burgeoning healthcare sector worldwide, along with the proliferation of care facilities define the growing market landscape of Hybrid OR.

Over the last decade, the healthcare industry is growing by leaps and bound due to the ever-increasing population prompting a tremendous need for effective treatment and care.  Besides a large number of market players providing technologies and equipment required in a Hybrid OR fosters the market growth across the globe. Simultaneously, the availability of advanced solutions that are enhancing the performance of healthcare professionals and caregiving facilities with improved surgical processes contributes to the market growth.

On the other hand, the high cost required for the initial set-up, installations and maintenance of a hybrid OR is expected to act as a headwind, impeding the market growth. However, the efficacy that an efficient hybrid OR provides is expected to support the market growth during the assessment period.

Global Hybrid Operating Room Market   - Segments

MRFR has segmented its analysis into four key dynamics for enhanced understanding.

By Techniques: Fluoroscopy and Data Acquisition, Rotational Angiography, and Digital Subtraction Angiography among others.

By Applications: Cardiovascular Surgery, Neurosurgery, Thoracic Surgery, and Endo-Bronchial Procedures among others.

By End-Users: Hospitals, Clinics, and Medical Research Firms, among others.

By Regions:  Europe, North America, APAC and the Rest-of-the-World.

Global Hybrid Operating Room Market – Geographical Analysis

Globally, the North American region is dominating the global Hybrid operating room market owing to substantial investments transpired into R&D activities in healthcare. The well-developed economy of this region is fostering the market growth. Besides, the presence of many key players is positively impacting the market growth in the region.

Besides, some factors such as increasing number of surgeries, rising popularity of hybrid operating room, growing digital advancements in medical technology, and extensive uptake of Hybrid OS in the hospital and clinical settings are propelling the market growth in the region. 

The European region is another lucrative market for hybrid operating room standing at the second position. The market is heading with the augmenting demand for Hybrid OR in clinical settings. Undoubtedly, the resurging economy in the region is a dominant factor substantiating the market growth, increasing healthcare facilities.  Also, the increased funding in the rising numbers of specialty services offered by various health care providers provides impetus to the market growth in the region.

The hybrid OR market in the Asia Pacific region is rapidly emerging as a promising market.  Burgeoning healthcare sector along with the increasing prevalence of chronic diseases and increasing number of surgeries defines the market landscape in the region. Furthermore, rapidly improving economic conditions along with the market penetration of healthcare technology in the region provide impetus to the market growth in the APAC. Additionally, the hybrid OR market in the APAC with some of its untapped regions offers high growth opportunities.

Global Hybrid Operating Room Market - Competitive Landscape

Highly competitive hybrid operating room market appears to be fragmented owing to the presence of several big & small market players along with new entrants churning the competition. Key players are adopting the strategic trends for business expansion in the emerging markets. Key market players are focusing on optimized situational awareness for customers, ensuring their mission success. Matured players, through various strategies such as collaboration, M&A activities, and innovations are continually seeking market expansion.

They increasingly invest in R&D activities and to develop cost-effective product portfolio. These players possess state of the art facilities to develop products and strong sales and distribution network which have helped them to gain the leadership position in the market. Marketers operating in the market are focusing on inbound lead generation more than ever.  Industry’s marketing executives look for ROI-oriented strategies that can pay off quickly.

Key Players:

Some of the eminent leaders of the market include Eschmann Equipment (UK), Cook Medical Inc. (US), General Electric Company (US), Maquet Holding BV & Co. KG (Germany), Johnson & Johnson Services, Inc. (US), Mediflex Surgical Products (US), NDS Surgical Imaging (US),  Mizuho OSI (US), Koninklijke Philips N.V (the Netherlands), STERIS plc. (US), Siemens Healthcare GmbH (Germany), and SISCO Ltd (India).       

        

Industry/ Innovation /Related News:

October 08, 2018 – IMRIS (US), a global provider of intra-operative imaging solutions announced its partnership with Siemens Healthineers (Germany, a medical technology company.  The strengthened collaboration is expected to enable the duo companies to leverage their areas of expertise to advance in the multimodality hybrid OR neurosurgical market, responding to the growing demand.

IMRIS will look after the sales of both the IMRIS ceiling-mounted and Siemens Healthineers fixed options for MRI, CT, and Angiography imaging modalities.  Further presenting a united front to Siemen’s customers, in turn, will enable them to address patient’s needs more quickly and effectively.

September 26, 2018 - Philips Healthcare products (U.K.), one of the global leaders providing Hybrid suits (OR) announced its partnership with Augusta University Health (US), an academic health center to co-create clinical solutions across Augusta’s hybrid operating room (OR) for diagnosis and treatment of Lung CA. Growing number of lung cancer cases are suggesting early detection and procedures which are pivotal to a patient’s ability to survive. Philips’ hybrid OR combines multiple techniques into one space, making it even easier and quicker for surgeons to diagnose lung cancer.

Brows More Healthcare Related Research Reports

Filters and Particle Monitoring Market Trends, Size | Growth Analysis, 2023

Microarray Analysis Market Trends, Applications | Growth Insights, 2027

Wearable Tracking Devices Market Trends, Growth | Size Analysis, 2023

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

 MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

 Contact:

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Test Strip Market Size, Profile, Segmentation, Vendor Landscape Forecast To 2021

Test Strip Market Size Application (Diagnosis {Urinalysis [UTI, Liver Disease]} Pregnancy Test) Type (Fluorescein, Diabetic Strips, Urine test strip) End Users (Consumers, Hospitals, Clinics, Diagnostic Laboratories) - Volume & Value Forecast to 2021

The global Test Strip Market size is expecting a sound growth at a CAGR of 12.8% during the forecasted period. Test strip is a type of diagnostic devices which is the most important tools in Point of Care (POC) diagnostics. These test strip helps to achieve rapid diagnosis of various critical diseases such as urinary tract infection (UTI), liver disease, kidney diseases, diabetes test, ophthalmic disease and others with precsion. Test strips are widely used for monitoring the blood glucose level in the diabetic patients. As per world Health Organization (WHO), it was estimated that in 2016, 420 million adult population is suffering from diabetes all over the world will and the number is expected to reach 625 million till 2040. The global test strip market is growing with the dynamic pace.

Increasing prevalence of diabetes, and other urinary tract diseases has supported the growth of this market. According to a recent study report published by the Market Research Future, The global test strip market is booming and expected to gain prominence over the forecast period. The market is forecasted to demonstrate a spectacular growth by 2021, surpassing its previous growth records in terms of value with a striking CAGR during the anticipated period (2017 – 2021).

The market is expected grow with the same trends during the forecast period. The major drivers supporting the growth of the market will be presence of huge diabetic patient population in Asia Pacific region like India and China. According to WHO (2014), 60% of the world’s total diabetic population lives in Asia region. Moreover, the global test strip market is driven by rising geriatric population, and rapid development in the test strips has driven the growth of the market. Moreover, changing lifestyle, and government initiatives for encouragement for the research & development has fuelled the market growth. On the other hand, availability of alternative methods for diagnosis like saliva collection devices has restrained the growth of global test strip market.

Global Test Strip Market - Competitive Analysis

The test strips are based on various technologies such as electrochemical and photometric. Majority of the test strips are based on electrochemical technology. The photometric technology market is expected to witness the highest growth. Roche Diagnostics, Lifescan, Inc., Abbott Laboratories, and Bayer are the leading players in the test strip market, by volume. These players possess state of art manufacturing facilities and strong sales and distribution network which have helped them to gain leadership position in the market. The other prominent players include Arkray Inc., Ascensia Diabetes Care Holdings Ag, B. Braun Melsungen AG, Chiltern Medicare Ltd, Henry Schein, Lifeassay Diagnostics (Pty), Siemens Healthcare, Taidoc Technology Corporation, and Teco Diagnostics among others are some of the small players that accounts a reasonable amount of share in the test strip market.  

The global Test Strip Market size is highly fragmented with the presence of many local players and international players. As a result, local players are focus on cost reduction and innovation to ensure sustainability. In addition, the international players implemented growth strategies through FDA approvals, collaborations to expand their overall market share. For instance, Abbot a leading player in the test strip market has received US Food and Drug Administration (FDA) clearance for its new product FreeStyle Lite blood glucose test strips that minimizes the interference during blood glucose testing, hence is fabricated for a better testing experience. This will help Abbott to create an impact on the patient pool and will help to increase its sales by volume.

Hoffmann-La Roche Ltd, Swiss multinational healthcare company focuses on the development and distribution of test strips. For this, in June 2017, Roche has acquired mySugr to form a leading open platform for digital diabetes management. Hence, the growing mergers and acquisitions, new product launches in the field of test strip has upsurged the growth of the market.

Hoffmann-La Roche Ltd (Switzerland), Siemens Ltd. (Germany), Abbott (US), B. Braun (Germany), LifeScan, Inc. (US), Chiltern MediCare Ltd. (US), Henry Schein, Inc. (US), Lifeassay Diagnostics (South Africa), Siemens Healthcare Private Limited (Germany), ARKRAY Inc. (US), Ascensia Diabetes Care Holdings AG. (Switzerland), TaiDoc Technology Corporation (Taiwan), Teco Diagnostics (US) are some of the prominent players at the forefront of competition in the Global Test Strip Market and are profiled in MRFR Analysis.

Brows More Healthcare Related Research Reports:

Lancet and Pen Needles Market Trends Analysis, Growth | Size Value, 2027

Microfluidic Devices Market Size Analysis, Trends | Share Value, 2025

Micropump Market by Share, Size, Growth and Analysis – 2024 | MRFR

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Lip Augmentation Market Share, Size, Cost Structure Analysis and Forecast To 2023

Lip Augmentation Market Share By Type (Temporary and Permanent Lip Augmentation), Lip Fillers (Fat Injection or Lipoinjection, Hyaluronic Acid Fillers, Lip Collagen Injections & Others), Distribution Channel – Global Forecast Till 2023

Lip Augmentation Market

The global lip augmentation market share is expected to grow at an approximate CAGR of 10.5% during forecast period, 2018–2023.

Rising participation of market players is one of the prominent factors driving the lip augmentation market. For instance, in 2018, Allergan plc launched a new JUVÉDERM advertising campaign created to empower the next generation of consumers to “JUVÉDERM IT.” The JUVÉDERM collection of fillers offers a complete range of dermal fillers for different patient needs. JUVÉDERM Ultra XC is used into the lips and perioral area for lip augmentation in adults over 21.

Various other factors such as increasing awareness about lip augmentation, rising geriatric population and rising demand for dermal fillers are also expected to propel the growth of the market.

However, side effects associated with lip fillers and high cost of treatment can hamper the market growth over the forecast period.

Lip Augmentation Market Segmentation

The global lip augmentation market is segmented based on type, lip fillers, distribution channel, and region.

The global market for lip augmentation, by type is segmented into temporary lip augmentation and permanent lip augmentation. The permanent lip augmentation segment is further classified as dermal graft, permanent lip implants, vermilion lip advancement and lip lift. The lip lift segment includes corner lip lift and upper lip lift.

The market, by lip fillers, is segmented into fat injection or lipoinjection, hyaluronic acid fillers, lip collagen injections, platelet-rich plasma (PRP), and others.

Based on distribution channel, the market is segmented into hospital pharmacies, clinics, retail pharmacies, drug stores, online pharmacies, and others.

The hospital pharmacies segment is anticipated to hold the largest market share owing to the increasing demand for cosmetic procedures. The online pharmacies are expected to grow at the highest CAGR owing to the rising cases of cosmetic problems.

Lip Augmentation Market Regional Analysis

The Americas dominated the global lip augmentation market share owing to the rising geriatric population. According to the Population Reference Bureau report, the number of Americans ages 65 and older is projected to double from 46 million today to over 98 million by 2060. Moreover, rising healthcare spending within the region is also boosting the lip augmentation market. In the US, the total healthcare spending reached USD 3.5 trillion in 2017 and by 2026; it is expected to reach USD 5.7 trillion.

In 2017, it was estimated that Europe stood second in the global lip augmentation market. This can be attributed to the rising research and development investments and technological advancements. For instance, in 2017, Allergan received FDA approval for its newest hyaluronic acid dermal filler, Juvéderm Vollure XC.

Asia Pacific was projected to be the fastest growing region in 2017. Factors such as growing medical tourism industry and increasing technological advancements within the region are boosting the regional markets of the Asia Pacific region.

On the other hand, the Middle East and Africa held least share in the global lip augmentation market due to the low per capita income, especially within the African region.

Lip Augmentation Market Key Players

Some of the key players in the global lip augmentation market are Allergan, Galderma Pharma S.A., Integra Lifesciences, Laboratories Vivacy SAS, Merz Pharma, Sinclair Pharma, Suneva Medical, Inc, Teoxane, Cynosure, Syneron, AQTIS Medical, Bioha Laboratories, Cytophil, Inc., Dr. Korman Laboratories, Inamed Corporation, and Anika Therapeutics Inc., and others.

Brows More Healthcare Related Research Reports at:

3D Bioprinting Market Report - Forecast to 2023 | MRFR

Poultry Vaccines Market Size, Trends | Growth Analysis, 2023

Real Time Health Monitoring Devices Market Share Analysis, Size | Application, 2025

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com